ABCL - 397
Therapeutic Architecture Rather Than Population Differences Drives Frontline Outcomes in T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Comparison-Specific Pooled Analysis of Rituximab-Era Cohorts
Adarsh Vardhan Tangella
Poster Presenter: Adarsh Vardhan Tangella
